MRNA vs STRO · rev $1.94B vs rev $62.0M
Moderna Inc (MRNA) versus Sutro Biopharma (STRO) — a side-by-side from cached financials, not a winner call.
Moderna Inc (MRNA) is a biotechnology company listed on NASDAQ. It is led by Stephane Bancel.
Sutro Biopharma (STRO) is a biotechnology company listed on NASDAQ.
Latest reported MRNA revenue for 2025-12-31 was $1.94B. Net income was -$2.82B. Revenue was down 39.9% from 2024-12-31 to 2025-12-31. MRNA currently screens at market cap $24.52B.
Latest reported STRO revenue for 2024-12-31 was $62.0M. Net income was -$227.5M. Revenue was down 59.6% from 2023-12-31 to 2024-12-31. STRO currently screens at market cap $470.8M.
MRNA currently screens at market cap $24.52B. STRO currently screens at market cap $470.8M.
Not investment advice. Open the MRNA and STRO stock pages for the full models.
Not investment advice.